Holen Sie sich die Stockscreener-App
247.07
1.36%
3.31
Handel nachbörslich:
247.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt STE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$243.76
Offen:
$243.86
24-Stunden-Volumen:
455.18K
Relative Volume:
0.72
Marktkapitalisierung:
$24.30B
Einnahmen:
$5.46B
Nettoeinkommen (Verlust:
$614.64M
KGV:
39.85
EPS:
6.2
Netto-Cashflow:
$778.00M
1W Leistung:
+11.69%
1M Leistung:
+8.35%
6M Leistung:
+12.70%
1J Leistung:
+5.68%
1-Tages-Spanne:
$242.90
$248.06
1-Wochen-Bereich:
$226.58
$248.06
52-Wochen-Spanne:
$200.98
$252.79
Steris Plc Stock (STE) Company Profile
Firmenname
Steris Plc
Sektor
Branche
Telefon
35312322000
Adresse
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Vergleichen Sie STE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
247.07 | 24.01B | 5.46B | 614.64M | 778.00M | 6.20 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-05-29 | Eingeleitet | Jefferies | Hold |
| 2024-10-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-04-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | Herabstufung | Needham | Buy → Hold |
| 2022-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-07 | Eingeleitet | Wolfe Research | Outperform |
| 2021-05-26 | Hochstufung | Needham | Hold → Buy |
| 2021-02-04 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-09 | Eingeleitet | Needham | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | Herabstufung | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | Eingeleitet | Goldman | Neutral |
| 2016-06-03 | Hochstufung | Northcoast | Neutral → Buy |
| 2015-06-12 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | Herabstufung | Griffin Securities | Buy → Hold |
| 2013-02-08 | Bestätigt | Griffin Securities | Buy |
| 2012-08-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | Bestätigt | JMP Securities | Mkt Outperform |
| 2011-02-09 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-12-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2010-04-07 | Bestätigt | CL King | Strong Buy |
| 2010-03-26 | Eingeleitet | CL King | Strong Buy |
| 2010-03-03 | Eingeleitet | Brean Murray | Hold |
Alle ansehen
Steris Plc Aktie (STE) Neueste Nachrichten
STERIS’s SWOT analysis: infection prevention leader faces tariff headwinds - Investing.com
Here's Why Steris (STE) is a Strong Growth Stock - sharewise.com
Steris Earnings: Robust Growth Across Segments; Full-Year Guidance Unchanged - Morningstar
STERIS plc (NYSE:STE) Q1 2026 Earnings Call Transcript - MSN
Understanding Steris (STE) Reliance on International Revenue - Yahoo Finance
Why STERIS (STE) Is Up 7.0% After Upbeat Outlook, Dividend Hike and CFO Transition - simplywall.st
KeyBanc’s Positive View on STERIS (STE) Driven by MedTech Momentum - Insider Monkey
STERIS plc: A Defensively Positioned MedTech Company with Strong Cash Generation - AInvest
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target - MSN
Is STERIS plc impacted by rising ratesVerified 200% Stock Tips - mustnews.co.kr
STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View - MSN
STERIS plc Q1 Results: Analysts Forecast 5.7% Revenue Growth for 2026 - AInvest
STERIS (NYSE:STE) Upgraded to Strong-Buy at Wall Street Zen - Defense World
What risks could impact STERIS plc stock performanceIntraday Movement Recap and Chart Summary - Newser
Morgan Stanley Maintains Steris PLC(STE.US) With Buy Rating, Raises Target Price to $295 - 富途牛牛
Steris Plc shares rise 2.73% intraday after Morgan Stanley raised price target to $295. - AInvest
Morgan Stanley Adjusts Price Target on STERIS to $295 From $276, Maintains Overweight Rating - MarketScreener
Jefferies Adjusts Price Target on STERIS to $250 From $248, Maintains Hold Rating - MarketScreener
STERIS CFO to step down, successor named - MSN
STERIS Reports Strong Q1 Earnings and Revenue Growth - TipRanks
Steris Receives Hold Rating from Needham Analyst - AInvest
What makes STERIS plc stock price move sharplyDaily Stock Movement Forecast with Accuracy - Newser
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
Earnings call transcript: STERIS Q1 2025 sees earnings beat, stock rises 5.93% - Investing.com Nigeria
Earnings call transcript: STERIS Q1 2025 sees earnings beat, stock rises 5.93% By Investing.com - Investing.com South Africa
Steris anticipates 8–9% reported revenue growth in fiscal 2026 as currency tailwinds offset tariff headwinds - MSN
STERIS plc's Q1 2026: Navigating Tariff Turbulence and Life Sciences Growth Challenges - AInvest
STERIS Reports Q1 Earnings and Revenue Beat, Raises '26 Sales View - AInvest
STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year - simplywall.st
Zacks Research Brokers Reduce Earnings Estimates for STERIS - Defense World
Steris Tops Expectations And Lifts Its 2026 Outlook - Finimize
Steris PLC | 8-K: STERIS Announces Financial Results for Fiscal 2026 First Quarter - 富途牛牛
STERIS plc reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Steris (STE) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Steris Q1 adjusted profit beats estimates - MarketScreener
Steris (STE) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
STERIS CFO Michael Tokich to step down after 17 years By Investing.com - Investing.com Nigeria
Steris PLC Reports Q1 2026 Earnings: EPS of $1.79 Beats Estimates, Revenue Hits $1.4 Billion - GuruFocus
STERIS CFO Michael Tokich to step down after 17 years - Investing.com
STERIS Announces Chief Financial Officer Transition - The Globe and Mail
STERIS plc Announces CFO Transition as Michael J. Tokich to be Succeeded by Karen L. Burton - Quiver Quantitative
Earnings Flash (STE) STERIS plc Reports Q1 Revenue $1.40B, vs. FactSet Est of $1.36B - MarketScreener
Earnings Flash (STE) STERIS plc Posts Q1 Adjusted EPS $2.34 per Share, vs. FactSet Est of $2.26 - MarketScreener
STERIS Names New CFO as Company Veteran Drives $22 Billion Market Value Growth - Stock Titan
STERIS Announces Financial Results for Fiscal 2026 First Quarter - Taiwan News
Sterilization Services Market to Reach $8.77B by 2033 Amid HAI - openPR.com
STERIS plc (NYSE:STE) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Competitive Positioning of STERIS plc: Is It Leading or LaggingFree Entry and Exit Strategy Optimizer Tool - Newser
STERIS plc : Healthcare Sterilization Industry Leader - MarketScreener
Is Now The Time To Look At Buying STERIS Plc (NYSE:STE)? - 富途牛牛
Autoclave Biological Indicator Monitoring Solutions Market - openPR.com
Finanzdaten der Steris Plc-Aktie (STE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):